FGFR

Inhibitory Selectivity

Catalog No.	Inhibitor Name	FGFR	FGFR1	FGFR2	FGFR3	FGFR4	Other
A10080	Ponatinib		****				Abl,PDGFRα,VEGFR2
A11159	BGJ398		****	****	****	**	VEGFR2,Lyn,Kit
A10137	Nintedanib		**	**	**	*	VEGFR3,VEGFR2,LCK
A10703	PD173074		**				VEGFR2,c-Src
A11411	Dovitinib		***		***		FLT3,c-Kit,VEGFR3/FLT4
A11075	AZD4547		****	****	****	*	KDR,IGFR
A10715	Danusertib		**				Aurora A,Abl,TrkA
A10953	Orantinib		*				PDGFRβ,Flk1
A10254	Brivanib		*				VEGFR2,Flk1,VEGFR1
A10198	Dovitinib Dilactic Acid		***		***		FLT3,c-Kit,VEGFR3/FLT4
A11753	MK-2461		**	**	**
A10162	Brivanib Alaninate		*				VEGFR2,Flk1,VEGFR1
A13211	SSR128129E		*				VEGFR2,PDGFRβ
A11558	SU5402		**
A15534	BLU9931		*	*	*	****
A12357	FIIN-2		****	***	**	**	FLT3,c-Kit,VEGFR3/FLT4
A14415	CH5183284		***	***	***	*	VEGFR2
A11244	LY2874455		****	****	***	***
A15957	Erdafitinib
A10508	KW-2449		**				FLT3, Bcr-Abl, Aurora A, PDGFRβ, IGF-1R, EGFR
A10699	Pazopanib HCl	*					VEGFR1, VEGFR2, VEGFR3, PDGFR, c-Kit, c-Fms
A11518	Pazopanib	*					VEGFR1, VEGFR2, VEGFR3, PDGFR, c-Kit, c-Fms
A13111	R 1530		*				Chk2, KDR, FGFR, Aurora A, Cdk2, VEGFR-2, PDGFRβ
A15073	E-3810		***	**			VEGFR1, VEGFR2, VEGFR3
A15848	FIIN-3		***	**	**	**
A15957	Alofanib (RPT835)

Notes:
1.Hover mouse over " * " to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of " * " is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.

Quick View
KW-2449

Catalog No. A10508
Quick View

添加到收藏
FLT3/FGFR/Bcr-Abl/Aurora 抑制剂

KW-2449是FLT3、ABl、ABl-T315I和Aurora激酶的多激酶抑制剂。了解更多

Bulk Inquiry Free Sample
Quick View
XL-228

Catalog No. A13069
Quick View

添加到收藏
IGF-1R, Aurora, FGFR, ABL, SRC 抑制剂

XL228是靶向IGF1R，AURORA激酶，FGFR1-3，ABL和SRC家族激酶的蛋白激酶抑制剂。XL228是一种Aurora A抑制剂（IC50，f3 nmol/L），对ABL1（Ki，5 nmol/L）以及BCR-ABL1 T315I（Ki，1.4 nmol/L）激酶显示出有效的生化活性。了解更多

Bulk Inquiry Free Sample
Quick View
AP24534 (Ponatinib)

Catalog No. A10080
Quick View

添加到收藏
BCR-ABL 抑制剂

AP24534 (Ponatinib)是有效的多激酶和pan-BCR-ABL抑制剂。了解更多

Product Citations (6)

Bulk Inquiry Free Sample
- Aya Hasan Alshammari, .et al. Discrimination of hand-foot skin reaction caused by tyrosine kinase inhibitors based on direct keratinocyte toxicity and vascular endothelial growth factor receptor-2 inhibition, Biochem Pharmacol, 2022, Mar;197:114914 PMID: 35041812
- Yamamoto Y, .et al. Development of a sandwich enzyme-linked immunosorbent assay for the quantification of ponatinib in serum, Anal Biochem, 2019, Feb 13. pii: S0003-2697(18)31083-2 PMID: 30771339
- N Naganna, .et al. Amino alkynylisoquinoline and alkynylnaphthyridine compounds potently inhibit acute myeloid leukemia proliferation in mice, EBioMedicine, 2019, Jan 24. pii: S2352-3964(19)30012-X PMID: 30686755
- Takuya Hirao, .et al. Altered intracellular signaling by imatinib increases the anti-cancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia cells, Cancer Sci, 2018, Jan; 109(1): 121-131 PMID: 29121435
- Brittany M. Duggan, .et al. Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia, Sci Rep, 2017, 7: 1578 PMID: 28484277
- Fujita KI, .et al. Involvement of the Transporters P-Glycoprotein and Breast Cancer Resistance Protein in Dermal Distribution of the Multikinase Inhibitor Regorafenib and Its Active Metabolites, J Pharm Sci, 2017, Sep;106(9):2632-2641 PMID: 28479358
Quick View
Nintedanib esylate

Catalog No. A16197
Quick View

添加到收藏
RTK 抑制剂

Nintedanib esylate是多种受体酪氨酸激酶（RTK）和非受体酪氨酸激酶（nRTK）的有效抑制剂。了解更多

Product Citations (2)

Bulk Inquiry
- Thibaut Fourniols, .et al. Inhibition of Colorectal Cancer-Associated Fibroblasts by Lipid Nanocapsules Loaded With Acriflavine or Paclitaxel, Int J Pharm, 2020, Jun 30;584:119337 PMID: 32371002
- Majid Momeny, .et al. Cediranib, an inhibitor of vascular endothelial growth factor receptor kinases, inhibits proliferation and invasion of prostate adenocarcinoma cells, Eur J Pharmacol, 2020, 882:173298